
News|Articles|February 1, 2004
Lexapro (Escitalopram) FOREST
SSRI approved for generalized anxiety disorder
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Payers lean on step therapy, formulary exclusions as IRA reshapes Part D benefit design
2
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
3
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
4
Consolidative radiotherapy shows no survival benefit, added risk in SCLC
5


























